Problem

Sanvivo addresses the digitization gap facing local pharmacies. European pharmacies are largely small, independently operated businesses that are not equipped for online orders; orders may still be handled through paper notes or fax, while pharmacies struggle to scale, build digital customer loyalty, and compete with mail-order pharmacies. In Germany, pharmacies reportedly handle more than 120 million deliveries annually, mostly through manual processes, even as online pharmacies grow and local pharmacies continue to close.

The core use case is turning existing local pharmacy inventory, advice, and delivery capacity into a convenient digital service: a customer orders medication or over-the-counter products online, receives pharmaceutical advice where needed, and gets the order delivered quickly by a nearby pharmacy. For the pharmacy, the pain is both operational and economic: it risks losing online demand and e-prescriptions to large mail-order players while spending staff time on fragmented manual workflows. Sanvivo cites more than €82,000 in potential additional revenue per partner pharmacy.

Product / Service

Sanvivo is an API-driven pharmacy platform—effectively an operating system and marketplace layer for digitally connected pharmacies. It links local pharmacies with online shops, consumer delivery platforms, prescription applications, and e-prescription channels, while integrating with the pharmacy’s existing inventory or merchandise-management system. Orders from different sources are consolidated in one Sanvivo portal, where pharmacy staff can process, fill, and schedule them without needing their own e-commerce technology, marketing operation, or additional hardware.

On the customer side, the service supports online medication and OTC ordering, pharmaceutical consultation by chat, pickup or local delivery, and e-prescription workflows such as CardLink. Demand can come through partners such as Wolt, while pharmacy staff manage orders through a web interface and riders can complete deliveries. Sanvivo says pharmacies pay no monthly platform fee, so costs arise when orders are generated; the intended benefit is more digital reach and revenue with less administrative work and staff burden.

Market

Sanvivo competes in pharmacy software, healthtech SaaS, digital pharmacy infrastructure, and local pharmacy delivery or quick-commerce. Its positioning is different from a conventional online pharmacy: rather than replacing local pharmacies, it supplies the digital infrastructure and demand connections that allow them to participate online. Its main substitutes and competitive pressures are large mail-order pharmacies such as Shop-Apotheke, operated by Redcare Pharmacy, and DocMorris, which compete for online medication demand and e-prescriptions.

The company is operating rather than merely pre-revenue. Sanvivo was founded in 2021, participated in Y Combinator’s Winter 2023 batch, and its YC profile describes it as active. Its own website reports more than 1,000 partner pharmacies, 18 million customers in its network, and more than €82,000 of additional revenue per pharmacy. Third-party data is less consistent but supports commercial activity: PitchBook labels the company as generating revenue, while GetLatka estimated 2025 revenue of approximately $440,000. Funding disclosures also vary by database, although a May 2023 report described a $1 million seed deal with Heal Capital and identified total investment of $1.5 million at that point.